SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Kopra J))
 

Sökning: (WFRF:(Kopra J)) > (2023) > Increased Physiolog...

Increased Physiological GDNF Levels Have No Effect on Dopamine Neuron Protection and Restoration in a Proteasome Inhibition Mouse Model of Parkinson’s Disease

Olfat, Soophie (författare)
Karolinska Institutet,Karolinska Institute,University of Helsinki
Mätlik, Kärt (författare)
University of Helsinki
Kopra, Jaakko J. (författare)
University of Helsinki
visa fler...
Garton, Daniel R. (författare)
University of Helsinki
Iivanainen, Vilma H. (författare)
University of Helsinki
Bhattacharya, Dipabarna (författare)
University of Helsinki
Jakobsson, Johan (författare)
Karolinska Institutet,Lund University,Lunds universitet,Molekylär neurogenetik,Forskargrupper vid Lunds universitet,Molecular Neurogenetics,Lund University Research Groups
Petteri Piepponen, T. (författare)
University of Helsinki
Andressoo, Jaan Olle (författare)
Karolinska Institute,University of Helsinki
visa färre...
 (creator_code:org_t)
2023
2023
Engelska.
Ingår i: eNeuro. - 2373-2822. ; 10:2
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Parkinson’s disease (PD) is a progressive neurodegenerative disease that comprises a range of motor and nonmotor symptoms. Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of dopamine neurons in vitro and in vivo, and intracranial delivery of GDNF has been tested in six clinical trials for treating PD. However, clinical trials with ectopic GDNF have yielded variable results, which could in part result from abnormal expression site and levels caused by ectopic overexpression. Therefore, an important open question is whether an increase in endogenous GDNF expression could be potent in reversing PD progression. Here, we tested the therapeutic potential of endogenous GDNF using mice in which endogenous GDNF can be conditionally upregulated specifically in cells that express GDNF naturally (conditional GDNF hypermorphic mice; GdnfcHyper). We analyzed the impact of endogenous GDNF upregulation in both neuroprotection and neurorestoration procedures, and for both motor and nonmotor symptoms in the proteasome inhibitor lactacystin (LC) model of PD. Our results showed that upregulation of endogenous GDNF in the adult striatum is not protective in LC-induced PD model in mice. Since age is the largest risk factor for PD, we also analyzed the effect of deletion of endogenous GDNF in aged Gdnf conditional knock-out mice. We found that GDNF deletion does not increase susceptibility to LC-induced damage. We conclude that endogenous GDNF does not impact the outcome in the LC-induced proteasome inhibition mouse model of Parkinson’s disease.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

39UTR
dopamine
GDNF
mouse model
Parkinson’s disease

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

  • eNeuro (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy